New portable and ready-to-use upper respiratory drug delivery solution

11 Oct 2018

PureHale is valuable to pharmaceutical partners seeking a system that can carry a range of formulations and comes in various container sizes.

Aptar Pharma has released an industry first - PureHale, a new portable and ready-to-use drug delivery solution designed for upper respiratory care. PureHale is a revolutionary and intuitive device which – when used in combination with saline or other natural ingredient formulations – helps relieve the symptoms of upper respiratory system conditions.

New portable and ready-to-use upper respiratory drug delivery solution

PureHale was officially launched this week at CPhI Worldwide in Madrid and was a finalist in the CPhI Pharma Awards in the Excellence in Pharma: Drug Delivery Device category.

With the ongoing rise in pollution the need for upper respiratory relief is more prominent than ever. PureHale’s innovative technology distributes a continuous fine mist that gently cleanses, moisturizes and soothes the upper respiratory tract, in turn helping to reduce irritations caused by coughs, colds, allergies, respiratory problems and dry nose/throat issues.

PureHale’s portability allows consumers to relieve their symptoms wherever and whenever needed. Developed after researching and analysing the benefits and challenges of traditional nebulizer technology, this new user-friendly system was engineered for on-the-go consumers. Unlike traditional nebulizers, the PureHale system does not require batteries or the prefilling of a reservoir.

The PureHale technology platform benefits include the following:

  • Use of non-electronic technology eliminates need to plug in or charge
  • Quieter and lighter than traditional nebulizers
  • Complete portability and always ready to use
  • Includes mask and mouthpiece options, offering adaptable treatment and suitable for family use
  • Continuous cooling mist with fine particles (20-30µm) optimized for targeted deposition to the upper airways.
  • Guenter Nadler, Director Business Development at Aptar Pharma, said: “We are really excited to announce this newest Aptar Pharma innovation. We have seen a real need for a device of this kind – traditional nebulizers come with a set of challenges including complexities in setup, manual dexterity requirements and overall usage time. Meanwhile, challenges during medication administration include poor inhalation technique, duration of nebulization and understanding how to achieve optimal efficacy. PureHale has been designed specifically with these challenges in mind and offers a solution by simplifying the entire process.”

    Utilizing Aptar Pharma’s well-established Bag-on-Valve technology, the PureHale system preserves the integrity of the treatment solution while utilizing compressed air/nitrogen between the bag and can to create a continuous mist when actuated. This solution is valuable to pharmaceutical partners seeking a system that can carry a range of formulations, comes in various container sizes, while also offering differentiating and branding advantages.

    “PureHale enables pharmaceutical partners to expand their audience reach for their brand formulations, providing portable, symptomatic relief for upper respiratory system conditions,” said Thomas Klofac, President of Aptar Pharma’s Consumer Healthcare Division. PureHale provides brand differentiation via a range of personalization options and, with minimal parameter changes, existing filling processes can be easily adapted to fill PureHale. Aptar Pharma has extensive regulatory experience and this, combined with several standardized solutions, can satisfy a rapid-to-market launch objective.”

    Read More

    Related news

    Inaugural Bio Integrates conference highlights industry's inefficiency in developing products

    Inaugural Bio Integrates conference highlights industry's inefficiency in developing products

    18 Jun 2019

    Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.

    Read more 
    PASCOE Naturmedizin exhibits at CPhI Worldwide Exhibition in Frankfurt

    PASCOE Naturmedizin exhibits at CPhI Worldwide Exhibition in Frankfurt

    18 Jun 2019

    PASCOE Naturmedizin is one of Germany's 100 most innovative medium-sized enterprises. The success story of our family’s specialist naturopathy company began three generations and almost 125 years ago when Friedrich H. Pascoe's first pharmacy in Mülh...

    Read more 
    Liquid pharmaceuticals in the digital age

    Liquid pharmaceuticals in the digital age

    30 May 2019

    Inspiration, innovation and technical highlights from Bosch Packaging Technolgy's Pharmatag 2019.

    Read more 
    CPhI China opens with analysis pointing to a surge in growth in 2019

    CPhI China opens with analysis pointing to a surge in growth in 2019

    28 May 2019

    Regulatory reforms and harmonisation reported as key drivers of industry in China.

    Read more 
    Expert forecasts huge growth in Middle East manufacturing

    Expert forecasts huge growth in Middle East manufacturing

    16 May 2019

    UAE consumers and insurance companies are willing to pay for highest quality drug products.

    Read more 
    Lessons learned from early EU FMD adopters

    Lessons learned from early EU FMD adopters

    13 May 2019

    Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

    Read more 
    Manufacturing growth sees surging demand at CPhI South East Asia

    Manufacturing growth sees surging demand at CPhI South East Asia

    3 May 2019

    Number of visitors seeking a contract manufacturer was extremely high, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.

    Read more 
    Sirio’s Ayanda launches probiotic softgel

    Sirio’s Ayanda launches probiotic softgel

    23 Apr 2019

    Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil.

    Read more 
    Surge of Indian biosimilars market forecast in 2019

    Surge of Indian biosimilars market forecast in 2019

    22 Apr 2019

    India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production.

    Read more 
    New China-based biotechs fueling growth in manufacturing across China

    New China-based biotechs fueling growth in manufacturing across China

    9 Apr 2019

    New guidelines will see poorer quality manufacturers drop out of the market.

    Read more